Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results

Go back to Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results
(NASDAQ: NAGE) Delayed: 3.06 +0.02 (0.66%)
Previous Close $3.04    52 Week High
Open $3.03    52 Week Low
Day High $3.06    P/E N/A 
Day Low $3.00    EPS
Volume 518,621